Skip to main content
AVECHO BIOTECHNOLOGY LIMITED logo

AVECHO BIOTECHNOLOGY LIMITED — Investor Relations & Filings

Ticker · AVE ISIN · AU0000047441 LEI · 529900FA9G9T82C2LV25 ASX Manufacturing
Open in API
Filings indexed 881 across all filing types
Latest filing 2026-06-02 Share Issue/Capital Cha…
Country AU Australia
Listing ASX AVE

About AVECHO BIOTECHNOLOGY LIMITED

https://avecho.com.au/

Avecho Biotechnology Limited develops and commercializes human and animal health products using its proprietary drug delivery system, Tocopheryl Phosphate Mixture (TPM®). Derived from Vitamin E, TPM® is designed to enhance the solubility and absorption of active ingredients through the skin and digestive tract. The company focuses on applying this technology to pharmaceuticals, nutraceuticals, and animal health sectors. A primary area of development includes medicinal cannabis, where Avecho has produced high-bioavailability cannabidiol (CBD) softgel capsules for therapeutic use. The company’s portfolio also includes applications in pain management and dermatology, leveraging TPM® to improve the delivery of poorly soluble molecules and enhance the efficacy of existing treatments.

Recent filings

Filing Released Lang Actions
Notification regarding unquoted securities - AVE 6 pages 18.9KB
Share Issue/Capital Change Classification · 92% confidence The document is an ASX Appendix 3G notification detailing the issue of unquoted equity securities (options under an employee incentive scheme), including issue dates, quantities, and terms. This is a direct announcement of a new share issue/capital change rather than financial results or management changes. It matches the Share Issue/Capital Change category.
2026-06-02 English
Final Director's Interest Notice 2 pages 231.9KB
Director's Dealing Classification · 98% confidence The document is an ASX Appendix 3Z “Final Director’s Interest Notice” under Listing Rule 3.19A.3, which discloses a director’s personal relevant interests in securities. This corresponds to insider share transactions and holdings by company directors. According to the filing categories, this is a Director’s Dealing report.
2026-06-01 English
Notification of cessation of securities - AVE 4 pages 14.8KB
Share Issue/Capital Change Classification · 90% confidence The document is an ASX Appendix 3H “Notification of cessation of securities,” detailing the lapse of options and the resulting change in issued capital. This is a capital change announcement (options ceasing), not a financial report, management change, dividend notice, etc. It best fits the Share Issue/Capital Change category (SHA).
2026-06-01 English
Small Holding Share Sale Facility 9 pages 739.3KB
Regulatory Filings Classification · 78% confidence The document is an ASX announcement detailing the establishment of a “Small Holding Share Sale Facility” under the company’s constitution and ASX Listing Rules. It is not an earnings release, financial report, board/management change, dividend notice, proxy statement, share issue, buyback or other specific category. It is a general regulatory announcement about a share sale facility not covered by the more narrowly defined categories. Therefore, it best fits the fallback category for miscellaneous regulatory filings (RNS).
2026-05-26 English
2026 Annual General Meeting Results 2 pages 158.9KB
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is an ASX announcement dated 26 May 2026 detailing the resolutions voted on at the company’s Annual General Meeting, including proxy instructions and poll results for each resolution. It provides the official voting results of shareholders at the AGM. This aligns directly with the classification of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-25 English
Chair's Address and CEO Presentation 22 pages 2.0MB
AGM Information Classification · 92% confidence The document is an ASX announcement titled “Chair’s Address & CEO Presentation” and includes the full Chair’s address and CEO slide deck for the Annual General Meeting on 26 May 2026. It constitutes presentation materials shared at the AGM rather than a standalone earnings release, regulatory filing or proxy, fitting the definition of AGM Information (AGM-R).
2026-05-25 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.